Overview
HPLC purity describes the proportion of the target substance among all chromatographically detected, UV-active components of a sample. Peptide content (net peptide content), by contrast, states what proportion of the weighed material by mass is actually peptide. The two values answer different questions and cannot be converted into one another.
Scientific background
Chromatographic purity
Purity is normally determined by reversed-phase HPLC with UV detection at 210–220 nm and expressed as area per cent: the area of the main peak divided by the sum of all integrated peak areas. This captures peptide-related impurities that can be separated chromatographically – deletion and truncated sequences, incompletely deprotected molecules, diastereomers resulting from racemisation, and oxidised or deamidated forms, for example. The value is relative and method-dependent. Substances that do not absorb at the measurement wavelength, and impurities that co-elute with the main peak, are not reflected in it.
Net peptide content
A lyophilised peptide never consists entirely of peptide. It also contains counterions from synthesis and purification (such as trifluoroacetate or acetate), bound water – lyophilisates are hygroscopic – and possibly residual solvents and inorganic salts. Peptide content is therefore determined by separate methods, chiefly quantitative amino acid analysis after acid hydrolysis or nitrogen elemental analysis. As a rule it is well below 100 %, even when chromatographic purity is very high.
Side by side
| Aspect | HPLC purity | Peptide content |
|---|---|---|
| Question | What share of the peptide signals belongs to the target sequence? | How much of the weighed material is peptide? |
| Typical method | RP-HPLC with UV detection | Amino acid analysis, elemental analysis |
| Reference | Sum of peak areas | Total mass of the sample |
| Not captured | Water, salts, counterions, co-eluting substances | Distribution between target and by-products |
Practical significance
Anyone preparing a solution of defined concentration needs to take the peptide content into account, not just the purity. Conversely, a high peptide content says nothing about whether the peptide present has the correct sequence. Both figures are batch-specific and should be documented together with the method used. Values from different batches or laboratories are comparable only if the methods are comparable too. Because structurally related impurities can also respond in sensitive assays, it is worth looking at the chromatogram itself and not just at the percentage.
Molecular data
No molecular data is recorded for this entry.
State of research
The distinction between purity and content is firmly established in pharmaceutical analysis: pharmacopoeial monographs for peptide active substances treat related substances and assay as separate tests. For research peptides, however, the terms are not used consistently, which is why stating the method is essential. Mant et al. (2007) give a methodological overview of peptide HPLC.
Sources
The sources for this entry are currently being verified by the editorial team and will appear once verified.
Safety and research notes
- Purity and content figures apply only to the batch tested; do not transfer values to other batches.
- Do not compare results obtained with different methods directly.
- The safety data sheet applies to handling the substance. For research use only; not for use in humans or animals.